FDA.report

Application 090560

Type
ANDA
Sponsor
ANTIBIOTICE

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001NAFCILLIN SODIUMNAFCILLIN SODIUMINJECTABLE;INJECTIONEQ 1GM BASE/VIALNoNo
002NAFCILLIN SODIUMNAFCILLIN SODIUMINJECTABLE;INJECTIONEQ 2GM BASE/VIALNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
36000-175NafcillinNafcillinClaris Lifesciences, Inc.ANDACurrent
36000-176NafcillinNafcillinClaris Lifesciences, Inc.ANDACurrent
44567-221NafcillinNafcillinWG Critical Care, LLCANDACurrent
44567-221NafcillinNafcillinWG Critical Care, LLCANDACurrent
44567-221NafcillinNafcillinWG Critical Care, LLCANDACurrent
44567-222NafcillinNafcillinWG Critical Care, LLCANDACurrent
44567-222NafcillinNafcillinWG Critical Care, LLCANDACurrent
44567-222NafcillinNafcillinWG Critical Care, LLCANDACurrent
67850-031NafcillinNafcillin InjectionMethapharm Inc.ANDACurrent
67850-031NafcillinNafcillin InjectionMethapharm Inc.ANDACurrent
67850-031NafcillinNafcillin InjectionMethapharm Inc.ANDACurrent
67850-031NafcillinNafcillin InjectionMethapharm Inc.ANDACurrent
67850-031NafcillinNafcillin InjectionMethapharm Inc.ANDACurrent
67850-032NafcillinNafcillin InjectionMethapharm Inc.ANDACurrent
67850-032NafcillinNafcillin InjectionMethapharm Inc.ANDACurrent
67850-032NafcillinNafcillin InjectionMethapharm Inc.ANDACurrent
67850-032NafcillinNafcillin InjectionMethapharm Inc.ANDACurrent
67850-032NafcillinNafcillin InjectionMethapharm Inc.ANDACurrent
70860-116Nafcillinnafcillin sodiumAthenex Pharmaceutical Division, LLC.ANDACurrent
70860-116Nafcillinnafcillin sodiumAthenex Pharmaceutical Division, LLC.ANDACurrent
70860-116Nafcillinnafcillin sodiumAthenex Pharmaceutical Division, LLC.ANDACurrent
70860-117Nafcillinnafcillin sodiumAthenex Pharmaceutical Division, LLC.ANDACurrent
70860-117Nafcillinnafcillin sodiumAthenex Pharmaceutical Division, LLC.ANDACurrent
70860-117Nafcillinnafcillin sodiumAthenex Pharmaceutical Division, LLC.ANDACurrent